Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$764,957
+$181,968 QoQ
Shares Held
3,012
+26.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#3,266
of 4,663 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wall Street Financial Group, Inc. holds $5,403,218 across 7 Drug Manufacturers - General names. JNJ ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,213 | $2,654,338 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,012 | $764,957 | |
| 3 | ABBV |
AbbVie Inc.
|
2,504 | $630,106 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,580 | $460,030 | |
| 5 | AMGN |
Amgen Inc
|
993 | $359,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,552 | $322,419 | |
| 7 | PFE |
Pfizer Inc
|
8,795 | $211,783 |
All Filings in JNJ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $764,957 | 3,012 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $582,989 | 2,385 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $460,877 | 2,227 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $377,885 | 2,038 | Shares | Sole | 2026-01-16 | |
| 2025-06-30 | $268,534 | 1,758 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||